Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Injectables: SOP for Internal Audits

Posted on By

SOP for Internal Audits

Standard Operating Procedure for Internal Audits

1) Purpose

The purpose of this SOP is to establish a procedure for conducting internal audits to verify compliance with regulatory requirements, company policies, and quality management systems.

2) Scope

This SOP applies to all departments and processes within the pharmaceutical manufacturing facility subject to internal audit.

3) Responsibilities

3.1 Quality Assurance (QA) Manager
– Plan and schedule internal audits.
– Ensure audit findings are addressed and closed within specified timelines.
3.2 Audit Team
– Conduct audits in accordance with this SOP and applicable audit protocols.
– Document audit findings accurately and objectively.
3.3 Department Heads
– Cooperate with auditors during audits.
– Implement corrective actions as directed based on audit findings.

See also  Injectables: SOP for Validation of FFS Machine Process

4) Procedure

4.1 Audit Planning
4.1.1 Determine audit objectives, scope, and criteria based on regulatory requirements and company policies.
4.1.2 Prepare an audit schedule including audit dates, departments to be audited, and audit team members.
4.2 Audit Execution
4.2.1 Conduct opening meeting to introduce audit team, explain audit objectives, and outline audit process.
4.2.2 Review documents, records, and procedures to assess compliance with established criteria.
4.3 Audit Reporting
4.3.1 Document audit findings, including non-conformities and observations.
4.3.2 Prepare an audit report summarizing findings, conclusions, and recommendations.
4.4

Corrective Actions
4.4.1 Assign responsibility for corrective actions to address identified non-conformities.
4.4.2 Verify implementation and effectiveness of corrective actions through follow-up audits or reviews.
4.5 Audit Closure
4.5.1 Conduct closing meeting to discuss audit findings, conclusions, and any outstanding issues.
4.5.2 Obtain management approval of the audit report and closure of audit findings.

See also  Injectables: SOP for Requalification of Equipment and Systems

5) Abbreviations, if any

– QA: Quality Assurance

6) Documents, if any

– Audit Schedule
– Audit Reports
– Corrective Action Reports

7) Reference, if any

– FDA Guidance for Industry: Quality Systems Approach to Pharmaceutical CGMP Regulations
– ICH Q10 Pharmaceutical Quality System

8) SOP Version

Version 1.0

Injectables Tags:Analytical method validation for injections, Aseptic media fill trials SOP, Bioburden testing for injections, Cleaning validation for injection equipment, Emulsion stability testing for injections, Formulation development for injections, Homogeneity testing for injections, IM injection SOP, Injection filling volume accuracy, Injection stability testing, Intramuscular injection procedure, Intravenous injection guidelines, IV injection SOP, Needle assembly for syringes SOP, Packaging integrity testing for injections, Particle size analysis for injections, Pre-filled syringe stability testing, Product sterility in aseptic processing, Reconstitution testing for injections, SC injection SOP, Subcutaneous injection technique, Syringe filling and capping SOP, Syringe labeling and inspection SOP, Temperature mapping in storage areas, Viscosity testing for injections

Post navigation

Previous Post: SOP for Dissolution Testing
Next Post: SOP for Minimum and Maximum Stock Levels

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version